Financials
Financial year 2025
Arega Pharma from Mechelen, company number BE0722544585, closed financial year 2025 with a result of € 6.4 million after tax. For that financial year Arega Pharma recorded revenue of € 63.4 million and equity of € 9.8 million. Compared with financial year 2024, the result moved from € 4 million to € 6.4 million. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.
€ 9.8 million
▼ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6.4 million
▲ 58% vs 2024
Profit after tax over the fiscal year.
€ 5,588
Cash and bank balances on the last day of the fiscal year.
€ 5 million paid out
79 % of the profit went to the shareholders, mostly to Arega Health (100 % of the shares). That is where the money ends up.
People and assets in 2025
53.3
▲ 0.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 7 million
▼ 4% vs 2024
€ 130,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 355,376
▲ 115% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 31.6 million
▲ 39% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 240 days on average.
€ 6.8 million
▼ 20% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 49,102,731 | € 51,152,897 | € 55,848,755 | € 63,376,460 | ▲ 13% |
| Profit after taxes | € 1,728,241 | € 2,441,222 | € 4,029,627 | € 6,350,191 | ▲ 58% |
| Equity | € 4,693,861 | € 7,135,083 | € 11,164,710 | € 9,801,971 | ▼ 12% |
| Total debts | € 15,224,954 | € 21,556,111 | € 31,286,979 | € 43,520,336 | ▲ 39% |
| Cash | - | - | - | € 5,588 | |
| Retained profit | € 4,493,861 | € 6,935,083 | € 10,964,710 | € 9,581,971 | ▼ 13% |
| Dividend | € 0 | € 0 | € 0 | € 5,000,000 | |
| Balance sheet total | € 20,591,815 | € 29,388,165 | € 43,048,660 | € 54,163,278 | ▲ 26% |
| Employees (FTE) | 52.7 | 54.8 | 52.7 | 53.3 | ▲ 0.6 |
Key figures of Arega Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Arega Pharma?
What happened at Arega Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Exactly Right Management BV stepped down as director. NBB
- CmmB BV stepped down as director. NBB
- Metriora BV stepped down as director. NBB
- R.Chibel BV stepped down as director. NBB
- Organova BV stepped down as director. NBB
- Jalissense BV stepped down as director. NBB
- BrandNomad BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 6.4 million (▲ 58% vs 2024). Source: NBB ↗
In short
From € 1.7 million profit in 2022 to € 6.4 million profit in 2025.
Paid € 4.6 million in corporate taxes since 2022.
Best year ever: 2025, with € 6.4 million profit.
Paid out € 5 million in dividends to the owners in total.
Management
The shares are held by Arega Health (100%).
Directors
According to the 2025 annual accounts
Managing director · represented by Stefanie Pieraets
since 2026 · until 2032
Director · represented by Anne-Sophie Gernay
since 2026 · until 2032
Director · represented by Alain De Buf
since 2026 · until 2032
Director · represented by Rémy Chibel
since 2026 · until 2032
Director · represented by Dirk Schollaert
since 2026 · until 2032
Director · represented by Stefan De Ridder
since 2026 · until 2032
Director · represented by Ann Tielemans
since 2026 · until 2032
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Stationsstraat 55
2800 Mechelen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
All companies at this address →ALCON
€ 50.9 million revenue · 2025
Protostars
Spectricity
€ 118,664 revenue · 2025
Arega Health same network
€ 5.8 million gross margin · 2025
Let's App
€ -1.4 million gross margin · 2025
+4 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
DNS
TransIP DNS
Domain
Domain
arega.com
Registered
2008-08-01
Registrar
Key-Systems GmbH
Expires
2026-08-01
Website info
Features
Security
Network
Details
- Company number
- 0722.544.585
- VAT number
- BE 0722.544.585
- Registered office
- Stationsstraat 55, 2800 Mechelen
- Names & denominations
- Arega Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 March 2019
- Peppol
- Active · Active since 29 Dec 2025
- Contact
- arega.com [email protected]
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Groothandel in reinigingsmiddelen
Groothandel in andere voedingsmiddelen, neg
Groothandel in parfumerieën en cosmetica
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering